Table 1.
Demographics and clinical characteristics of the study population (n = 70).
| With Persistent Infection (n = 6) |
Without Persistent Infection (n = 64) |
p-Value | |
|---|---|---|---|
| Age (years) | 66.6 ± 6.6; 64.5 (62–68) | 68.5 ± 6.2; 70 (66.5–72) | 0.14 |
| Gender (males, %) | 3 (50.0) | 27 (42.1) | 0.51 |
| BMI (kg/m2) | 22.8 ± 2.0; 22.5 (21–25) | 24.4 ± 3.6; 24 (22–26) | 0.28 |
| CCI | 4.3 ± 1.5; 4 (3–5) | 4.0 ± 1.4; 4 (3–5) | 0.72 |
| Smoking (%) | 2 (33.3) | 4 (6.2) | 0.07 |
| Operated joint (THA, %) | 4 (66.6) | 39 (60.9) | 0.57 |
| Anticoagulants (%) | 2 (33.3) | 16 (25.0) | 0.48 |
| Antiplatelets (%) | 1 (16.6) | 9 (14.0) | |
| Vitamin K antagonists (%) | 0 (0.0) | 1 (1.5) | |
| NOACs (%) | 1 (16.6) | 6 (9.3) |
Data are presented as mean ± SD, median and interquartile range (IQR), or as absolute frequency (percentage) when appropriate. The non-parametric Wilcoxon rank-sum test and the chi-squared test were used for comparison between groups. Abbreviations: BMI, Body Mass Index; CCI, Charlson Comorbidity Index; THA, Total Hip Arthroplasty; NOAC, Novel Oral Anticoagulant.